Speakers - 2020
Eileen Ryan obtained her PhD in Nutritional Sciences from University College Cork. Relocating to Australia in 2008 she took up a post at the Centre for Drug Candidate Optimization (CDCO) in Monash University. Her work here focused on in vitro drug metabolism and on MS based identification and structural elucidation of drug metabolites. In December 2014, she re-located to the University of Melbourne to work with Professor Gavin Reid at the Institute of Molecular Sciences & Biotechnology. Here her research was MS based lipid analysis relating to the onset and progression of disease states.
In 2018, under the guidance of Dr. Susan Joyce (APC Microbiome Ireland), Eileen was awarded an APEX fellowship to examine the metabolic etiology of Inflammatory Bowel Disease (IBD) via lipidome, metabolome and microbiome multivariate analyses (IBD-ome). Most recently, Eileen was awarded a prestigious MSCA fellowship focused on examining the role of microbial Oxylipins in the MIcrobiome:hosT dialogue (OMIT) and thus will contribute towards a molecular understanding of how microbe-host interactions influence human health. Her research interests include lipidomics (both mammalian & bacterial), biomarker discovery, metabolic pathways and nutritional biochemistry.
Keynote Speaker 2020
Prof. Joanna McGouran
Schuler Assistant Professor
Trinity College Dublin
Joanna was appointed as the Schuler assistant Professor in Translational Organic Chemistry in TCD in 2016. Research in the group focuses on bio-molecule modification to create new tools to study biological systems with a specific focus on deubiquitinating enzymes and DNA damage repair. We use mass spectrometry to study endogenous enzyme activity using activity-based protein profiling techniques.
Dr. Eileen Ryan
APEX Fellow at APC Microbiome Institute
Dr Ryan investigates the metabolic etiology of Inflammatory Bowel Disease (IBD) via lipidome, metabolome and microbiome multivariate analyses (IBD-ome). Most recently, Eileen was awarded a prestigious MSCA fellowship focused on examining the role of microbial Oxylipins in the MIcrobiome:hosT dialogue (OMIT) and thus will contribute towards a molecular understanding of how microbe-host interactions influence human health.
I have graduated with a 1st Class Honours Degree in Forensic Chemistry (IT Sligo, Ireland). Since June 2018 I have been employed at Celignis Limited, while completing a PhD in Analytical Chemistry at the University of Limerick. Celignis is a spin-out company from the Carbolea Biomass Research Group (UL) and was formed as a result of the development of near infrared models that allow the extremely rapid prediction of biomass properties. I am involved in the development of those new rapid analysis techniques, based on NIR spectroscopy and chemometrics, which will improve pre-existing models and create new ones. I have been developing predictive spectroscopic models for several projects such as UNRAVEL (from June 2018) and BIORESCUE (from October 2018).
Dr. Diego Cobice
Director of Mass Spectrometry
I obtained my MSc and PhD in Applied Mass Spectrometry from the University of Edinburgh. I am currently the Director of the Mass Spectrometry Centre at (BMRSI) Ulster University, where I operate the centres MS facilities, supporting both internal research projects and my own. My research interest is focused on the development of a novel MS imaging platform for the identification and quantitation of molecular signatures in degenerative diseases, specifically endocrine-related diseases.
Dr. Sanja Trajkovic
Head of Proteomics & Analytical Science
At Nuritas our mission is clear, we want to use our unique capabilities to tackle the health challenges facing the world of today as well as the world of tomorrow and, ultimately, improve the lives of billions of people around the globe.
Dr. Sara Carillo
Applications Development Team Leader
Dr. Sara Carillo is the applications development team lead in the Characterization and Comparability Laboratory in NIBRT. Sara completed her PhD in Chemical Science at the University of Naples in 2013 working on the structural characterization of bacterial glycoconjugates. In 2015, Sara joined Dr. Jonathan Bones’s research group in NIBRT, working on CHO cell glycome and biotherapeutics characterization.